Analyst consensus rating
Tenaya Therapeutics Analyst Rating: none
Direct answer
Tenaya Therapeutics's consensus rating is none.
6 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.67.
Forecast evidence checked November 21, 2026.
Get free Tenaya Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.29
- Average price target
- $3.67
- High price target
- $6.00
- Low price target
- $2.00
- Low target gap
- +597.8%
- Target upside
- +1,179.4%
- High target gap
- +1,993.5%
- Target range width
- 1,395.7%
- Consensus rating
- none
- Analysts
- 6
- Evidence date
- November 21, 2026
- Valid through
- November 28, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Tenaya Therapeutics?
Tenaya Therapeutics has a verified none consensus. The same dataset has an average price target of $3.67.
How far are Tenaya Therapeutics's low and high targets from the recorded price?
The low target implies +597.8%, while the high target implies +1,993.5%.
How many analysts are included in Tenaya Therapeutics's consensus?
The verified consensus includes 6 analysts.
How is Tenaya Therapeutics's target upside or downside calculated?
The average target of $3.67 is divided by the recorded price of $0.29, then one is subtracted to produce +1,179.4%. This does not guarantee a future return.
When was Tenaya Therapeutics's analyst forecast verified?
The data was verified on 2026-11-21. The dataset is valid through 2026-11-28.